160 related articles for article (PubMed ID: 26169830)
1. Expression of the CTCFL Gene during Mouse Embryogenesis Causes Growth Retardation, Postnatal Lethality, and Dysregulation of the Transforming Growth Factor β Pathway.
Sati L; Zeiss C; Yekkala K; Demir R; McGrath J
Mol Cell Biol; 2015 Oct; 35(19):3436-45. PubMed ID: 26169830
[TBL] [Abstract][Full Text] [Related]
2. CTCFL expression is associated with cerebral vascular abnormalities.
Sati L; Soygur B; Goksu E; Bassorgun CI; McGrath J
Tissue Cell; 2021 Oct; 72():101528. PubMed ID: 33756271
[TBL] [Abstract][Full Text] [Related]
3. BORIS/CTCFL expression activates the TGFβ signaling cascade and induces Drp1 mediated mitochondrial fission in neuroblastoma.
Makani VKK; Mendonza JJ; Edathara PM; Yerramsetty S; Pal Bhadra M
Free Radic Biol Med; 2021 Nov; 176():62-72. PubMed ID: 34534628
[TBL] [Abstract][Full Text] [Related]
4. Targeting CTCFL/BORIS for the immunotherapy of cancer.
Loukinov D
Cancer Immunol Immunother; 2018 Dec; 67(12):1955-1965. PubMed ID: 30390146
[TBL] [Abstract][Full Text] [Related]
5. The male germ cell gene regulator CTCFL is functionally different from CTCF and binds CTCF-like consensus sites in a nucleosome composition-dependent manner.
Sleutels F; Soochit W; Bartkuhn M; Heath H; Dienstbach S; Bergmaier P; Franke V; Rosa-Garrido M; van de Nobelen S; Caesar L; van der Reijden M; Bryne JC; van Ijcken W; Grootegoed JA; Delgado MD; Lenhard B; Renkawitz R; Grosveld F; Galjart N
Epigenetics Chromatin; 2012 Jun; 5(1):8. PubMed ID: 22709888
[TBL] [Abstract][Full Text] [Related]
6. Defining the relative and combined contribution of CTCF and CTCFL to genomic regulation.
Nishana M; Ha C; Rodriguez-Hernaez J; Ranjbaran A; Chio E; Nora EP; Badri SB; Kloetgen A; Bruneau BG; Tsirigos A; Skok JA
Genome Biol; 2020 May; 21(1):108. PubMed ID: 32393311
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies.
Hoffmann MJ; Müller M; Engers R; Schulz WA
Biochem Pharmacol; 2006 Nov; 72(11):1577-88. PubMed ID: 16854382
[TBL] [Abstract][Full Text] [Related]
8. Early vertebrate origin of CTCFL, a CTCF paralog, revealed by proximity-guided shark genome scaffolding.
Kadota M; Yamaguchi K; Hara Y; Kuraku S
Sci Rep; 2020 Sep; 10(1):14629. PubMed ID: 32884037
[TBL] [Abstract][Full Text] [Related]
9. The Diverging Routes of BORIS and CTCF: An Interactomic and Phylogenomic Analysis.
Jabbari K; Heger P; Sharma R; Wiehe T
Life (Basel); 2018 Jan; 8(1):. PubMed ID: 29385718
[TBL] [Abstract][Full Text] [Related]
10. Smad7 misexpression during embryonic angiogenesis causes vascular dilation and malformations independently of vascular smooth muscle cell function.
Vargesson N; Laufer E
Dev Biol; 2001 Dec; 240(2):499-516. PubMed ID: 11784079
[TBL] [Abstract][Full Text] [Related]
11. Expression of the epigenetic factor BORIS (CTCFL) in the human genome.
de Necochea-Campion R; Ghochikyan A; Josephs SF; Zacharias S; Woods E; Karimi-Busheri F; Alexandrescu DT; Chen CS; Agadjanyan MG; Carrier E
J Transl Med; 2011 Dec; 9():213. PubMed ID: 22168535
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of the embryo/cancer gene ECSA(DPPA2), the cancer/testis gene BORIS and the pluripotency structural gene OCT4, in human preimplantation development.
Monk M; Hitchins M; Hawes S
Mol Hum Reprod; 2008 Jun; 14(6):347-55. PubMed ID: 18467432
[TBL] [Abstract][Full Text] [Related]
13. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes.
Vatolin S; Abdullaev Z; Pack SD; Flanagan PT; Custer M; Loukinov DI; Pugacheva E; Hong JA; Morse H; Schrump DS; Risinger JI; Barrett JC; Lobanenkov VV
Cancer Res; 2005 Sep; 65(17):7751-62. PubMed ID: 16140943
[TBL] [Abstract][Full Text] [Related]
14. CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy.
Salgado-Albarrán M; Späth J; González-Barrios R; Baumbach J; Soto-Reyes E
NPJ Syst Biol Appl; 2022 Feb; 8(1):5. PubMed ID: 35132075
[TBL] [Abstract][Full Text] [Related]
15. Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice.
Bonyadi M; Rusholme SA; Cousins FM; Su HC; Biron CA; Farrall M; Akhurst RJ
Nat Genet; 1997 Feb; 15(2):207-11. PubMed ID: 9020852
[TBL] [Abstract][Full Text] [Related]
16. The downregulation of putative anticancer target BORIS/CTCFL in an addicted myeloid cancer cell line modulates the expression of multiple protein coding and ncRNA genes.
Teplyakov E; Wu Q; Liu J; Pugacheva EM; Loukinov D; Boukaba A; Lobanenkov V; Strunnikov A
Oncotarget; 2017 Sep; 8(43):73448-73468. PubMed ID: 29088719
[TBL] [Abstract][Full Text] [Related]
17. CTCFL (BORIS) mRNA Expression in a Peripheral Giant Cell Granuloma of the Oral Cavity.
Zambrano-Galván G; Reyes-Romero M; Bologna-Molina R; Almeda-Ojeda OE; Lemus-Rojero O
Case Rep Dent; 2014; 2014():792615. PubMed ID: 25114808
[TBL] [Abstract][Full Text] [Related]
18. The cancer-associated CTCFL/BORIS protein targets multiple classes of genomic repeats, with a distinct binding and functional preference for humanoid-specific SVA transposable elements.
Pugacheva EM; Teplyakov E; Wu Q; Li J; Chen C; Meng C; Liu J; Robinson S; Loukinov D; Boukaba A; Hutchins AP; Lobanenkov V; Strunnikov A
Epigenetics Chromatin; 2016; 9(1):35. PubMed ID: 27588042
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of mouse follistatin causes reproductive defects in transgenic mice.
Guo Q; Kumar TR; Woodruff T; Hadsell LA; DeMayo FJ; Matzuk MM
Mol Endocrinol; 1998 Jan; 12(1):96-106. PubMed ID: 9440814
[TBL] [Abstract][Full Text] [Related]
20. Comparative analyses of CTCF and BORIS occupancies uncover two distinct classes of CTCF binding genomic regions.
Pugacheva EM; Rivero-Hinojosa S; Espinoza CA; Méndez-Catalá CF; Kang S; Suzuki T; Kosaka-Suzuki N; Robinson S; Nagarajan V; Ye Z; Boukaba A; Rasko JE; Strunnikov AV; Loukinov D; Ren B; Lobanenkov VV
Genome Biol; 2015 Aug; 16(1):161. PubMed ID: 26268681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
